ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced...

Full description

Saved in:
Bibliographic Details
Main Authors LAM, Helen, CULP, Patricia, ROSENTHAL, Arnon, PEJCHAL, Robert, NIELSON, Nels P, LEE, Seung-Joo
Format Patent
LanguageEnglish
Published 26.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
AbstractList The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
Author ROSENTHAL, Arnon
LEE, Seung-Joo
NIELSON, Nels P
LAM, Helen
CULP, Patricia
PEJCHAL, Robert
Author_xml – fullname: LAM, Helen
– fullname: CULP, Patricia
– fullname: ROSENTHAL, Arnon
– fullname: PEJCHAL, Robert
– fullname: NIELSON, Nels P
– fullname: LEE, Seung-Joo
BookMark eNrjYmDJy89L5WTQd_QL8dR1djE2VgCxnPxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGRkaGZkbGDpaGhMnCoAWUQoHA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022162309A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022162309A13
IEDL.DBID EVB
IngestDate Fri Aug 02 08:57:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022162309A13
Notes Application Number: US202217581471
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220526&DB=EPODOC&CC=US&NR=2022162309A1
ParticipantIDs epo_espacenet_US2022162309A1
PublicationCentury 2000
PublicationDate 20220526
PublicationDateYYYYMMDD 2022-05-26
PublicationDate_xml – month: 05
  year: 2022
  text: 20220526
  day: 26
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Alector LLC
RelatedCompanies_xml – name: Alector LLC
Score 3.3979833
Snippet The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220526&DB=EPODOC&locale=&CC=US&NR=2022162309A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt7K1ydL0YcjapFSh61hb2dtYthQE6Yar-O-blE73tLdLDi4f8Mvd5XIXgGeB0aIohGu5wiYWLvrIoisqrIVDlgNpu2gx0PnO8ZhEOX6bDWYt-NzlwtR1Qn_q4ogKUUuF96o-rzf_l1isflu57YkP1bV-CbMhMxvvWGeNOsRk_pBPEpYEZhAM89QcT2uerVR93xspX-lIGdKuxgN_93VeymZfqYTncDxR8srqAlqy7MBpsPt7rQMncRPyVmSDvu0l9Ebj7NUKGEKGpvxE23KKZEbMsyhhqZGERp5yI4v4lCfhFTyFPAsiS408_1voPE_3p4muoV2uS3kDBiXYk0RSd1VIbK-WFFFBHWXZea7EuC9uoXtI0t1h9j2c6aaOiTukC-3q61s-KFVbicd6h34BFpd8JA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_Ejbm3zW3sw22Fjb4VbVPT-CBDm5S62VZsO3wTU1MYjCqzY__-kqKbT74dObh8wC93l-R3AXjmNlrkOXcMh5vYsPMOMsiScGNh4awrTActuorvHITYT-3XWXdWg88dF6aqE_pTFUeUiMok3stqv17_H2LR6m3lps0_ZNPqxUv6VN9mx4o1amGdDvtsEtHI1V23n8Z6OK10pnT1nd5A5kpHMsh2FB7Y-1DxUtb7TsU7g-OJtFeU51ATRRMa7u7vtSacBNsrbylu0be5gPYgTEaGSxHSlDSMVCwnRaoFLPEjGmuRp6Ux0xKfTVnkXcKTxxLXN2TP87-JztN4f5joCurFqhDXoBFs9wQWxFnmwjaXGUGEE0tGdj1H2HaH30DrkKXbw-pHaPhJMJ6PR-HbHZwqlboft3AL6uXXt7iXbrfkD9Vq_QIUPX8X
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-CD33+ANTIBODIES+AND+METHODS+OF+USE+THEREOF&rft.inventor=LAM%2C+Helen&rft.inventor=CULP%2C+Patricia&rft.inventor=ROSENTHAL%2C+Arnon&rft.inventor=PEJCHAL%2C+Robert&rft.inventor=NIELSON%2C+Nels+P&rft.inventor=LEE%2C+Seung-Joo&rft.date=2022-05-26&rft.externalDBID=A1&rft.externalDocID=US2022162309A1